Your browser doesn't support javascript.
loading
Epidemiology, microbiology, and diagnosis of infection in diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: A multicenter retrospective observational study.
Takahashi, Kyosuke; Uenishi, Norimichi; Sanui, Masamitsu; Uchino, Shigehiko; Yonezawa, Naoki; Takei, Tetsuhiro; Nishioka, Norihiro; Kobayashi, Hirotada; Otaka, Shunichi; Yamamoto, Kotaro; Yasuda, Hideto; Kosaka, Shintaro; Tokunaga, Hidehiko; Fujiwara, Naoki; Kondo, Takashiro; Ishida, Tomoki; Komatsu, Takayuki; Endo, Koji; Moriyama, Taiki; Oyasu, Takayoshi; Hayakawa, Mineji; Hoshino, Atsumi; Matsuyama, Tasuku; Miyamoto, Yuki; Yanagisawa, Akihiro; Wakabayashi, Tadamasa; Ueda, Takeshi; Komuro, Tetsuya; Sugimoto, Toshiro; Sasabuchi, Yusuke.
Afiliação
  • Takahashi K; Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan; Department of Anesthesiology and Critical Care Medicine, Kawasaki Municipal Hospital, 12-1 Shinkawadori, Kawasaki-ku, Kawasaki,
  • Uenishi N; Department of Emergency and General Internal Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
  • Sanui M; Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan.
  • Uchino S; Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan.
  • Yonezawa N; Department of Emergency and Critical Care Medicine, Yokohama City Minato Red Cross Hospital, 3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa 231-8682, Japan.
  • Takei T; Department of Emergency and Critical Care Medicine, Yokohama City Minato Red Cross Hospital, 3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa 231-8682, Japan.
  • Nishioka N; Department of Preventive Services, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Division of Nephrology, Department of Internal Medicine, Okinawa Prefectural Chubu Hospital, 281 Miyazato, Uruma, Okinawa 904-2293, Japan.
  • Kobayashi H; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, Ontario M4N 3M5, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, 27 King's College Cir, Toronto, ON M5S, Canada; Department of Intensive Care Medicine, Kameda Medi
  • Otaka S; Department of Emergency Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda Narita, Chiba 286-0124, Japan; Department of Emergency Medicine, Kumamoto Red Cross Hospital, Higashi, 2-1-1, Nagamineminami, Higashi-ku, Kumamoto 861-8520, Japan.
  • Yamamoto K; Department of Emergency Medicine, Musashino Red Cross Hospital, 1-26-1 Kyonancho, Musashino, Tokyo 180-8610, Japan.
  • Yasuda H; Department of Emergency Medicine, Musashino Red Cross Hospital, 1-26-1 Kyonancho, Musashino, Tokyo 180-8610, Japan; Department of Emergency Medicine, Jichi Medical University Saitama Medical Center, 847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan.
  • Kosaka S; Department of Medicine, Nerima Hikarigaoka Hospital, 2-5-1 Hikarigaoka, Nerima-ku, Tokyo 179-0072, Japan.
  • Tokunaga H; Department of Medicine, Nerima Hikarigaoka Hospital, 2-5-1 Hikarigaoka, Nerima-ku, Tokyo 179-0072, Japan.
  • Fujiwara N; Department of Medicine, Nerima Hikarigaoka Hospital, 2-5-1 Hikarigaoka, Nerima-ku, Tokyo 179-0072, Japan; Department of Medicine, Taito Municipal Taito Hospital, 3-20-5 Senzoku, Taito-ku, Tokyo 111-0031, Japan.
  • Kondo T; Department of Emergency and Critical Care Medicine, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi 460-0001, Japan.
  • Ishida T; Nanohana Clinic, 2-11-22 Katsuyamakita, Ikuno-ku, Osaka 544-0033, Japan; Department of Emergency Medicine, Yodogawa Christian Hospital, 1-7-50, Kunijima, Higashi Yodogawa-Ku, Osaka 533-0024, Japan.
  • Komatsu T; Department of Sports Medicine, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo 177-8521, Japan.
  • Endo K; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Department of General Internal Medicine, Tottori Prefectural Central Hospital, 730 Ezu, Tottori 680-0901, Japan.
  • Moriyama T; Department of Emergency Medicine, Hyogo Emergency Medical Center, 1-3 Wakinohamakaigandori, Chuo-ku, Kobe, Hyogo 651-0073, Japan; Department of Emergency Medicine, Saiseikai Senri Hospital, 1-1-6 Tsukumodai, Suita, Osaka 565-0862, Japan.
  • Oyasu T; Department of Emergency Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido 060-8648, Japan.
  • Hayakawa M; Department of Emergency Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido 060-8648, Japan.
  • Hoshino A; Department of Intensive Care Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Department of Emergency and Critical Care Medicine, Toyooka Public Hospital, 1094 Tobera, Toyooka, Hyogo 668-8501, Japan.
  • Matsuyama T; Department of Emergency Medicine, Kyoto Prefectural University of Medicine, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
  • Miyamoto Y; Department of Emergency Medicine, Kyoto Prefectural University of Medicine, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
  • Yanagisawa A; Department of Anesthesia, Gyoda General Hospital, 376 Mochida, Gyoda, Saitama, 361-0056, Japan; Department of Anesthesiology and Intensive Care, Gunma University Hospital, 3-39-15 Showamachi, Maebashi, Gunma, Japan.
  • Wakabayashi T; Department of Medicine, Suwa Central Hospital, 4300 Tamagawa, Chino, Nagano, 391-0011, Japan; Department of Cardiology, Suwa Central Hospital, 4300 Tamagawa, Chino, Nagano 391-0011, Japan.
  • Ueda T; Department of Emergency and General Internal Medicine, Rakuwakai Marutamachi Hospital, Agaru, Marutamachi, Shichihonmatus-dori, Nakagyo-ku, Kyoto 604-8401, Japan.
  • Komuro T; Department of Medicine, TMG Muneoka Central Hospital, 5-14-50 Kamimuneoka, Shiki, Saitama 353-0001, Japan; Department of Critical Care, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa 247-8533, Japan.
  • Sugimoto T; Department of Medicine, Shiga University of Medical Science, Setatsukinowacho, Otsu, Shiga 520-2192, Japan; Department of Medicine, National Hospital Organization Higashiohmi General Medical Center, 255 Gochicho, Higashiohmi, Shiga 527-8505, Japan.
  • Sasabuchi Y; Department of Real-World Evidence, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Diabetes Res Clin Pract ; 212: 111713, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38772502
ABSTRACT

AIMS:

We investigated the characteristics of infection and the utility of inflammatory markers in diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS).

METHODS:

A multicenter, retrospective observational study in 21 acute-care hospitals was conducted in Japan. This study included adult hospitalized patients with DKA and HHS. We analyzed the diagnostic accuracy of markers including C-reactive protein (CRP) and procalcitonin (PCT) for bacteremia. Multiple regression models were created for estimating bacteremia risk factors.

RESULTS:

A total of 771 patients, including 545 patients with DKA and 226 patients with HHS, were analyzed. The mean age was 58.2 (SD, 19.3) years. Of these, 70 tested positive for blood culture. The mortality rates of those with and without bacteremia were 14 % and 3.3 % (P-value < 0.001). The area under the curve (AUC) of CRP and PCT for diagnosis of bacteremia was 0.85 (95 %CI, 0.81-0.89) and 0.76 (95 %CI, 0.60-0.92), respectively. Logistic regression models identified older age, altered level of consciousness, hypotension, and higher CRP as risk factors for bacteremia.

CONCLUSIONS:

The mortality rate was higher in patients with bacteremia than patients without it. CRP, rather than PCT, may be valid for diagnosing bacteremia in hyperglycemic emergencies. TRIAL REGISTRATION This study is registered in the UMIN clinical trial registration system (UMIN000025393, Registered December 23, 2016).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Cetoacidose Diabética / Bacteriemia / Coma Hiperglicêmico Hiperosmolar não Cetótico Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Cetoacidose Diabética / Bacteriemia / Coma Hiperglicêmico Hiperosmolar não Cetótico Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article